Latest radiation poisoning Stories

2008-09-15 09:00:58

Cleveland BioLabs, a drug discovery and development company, has received a $774,183 grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to further study certain mitigating properties of Protectan CBLB502 in the context of hematopoietic damage from radiation exposure.

2008-08-07 09:01:05

Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced today the allowance from the U.S. Food and Drug Administration (FDA) to begin Phase I clinical trials in human volunteers with Protectan CBLB502, a drug under development for the treatment for Acute Radiation Syndrome (ARS).

2008-07-08 09:01:11

Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced today that its first patent for Protectan CBLB502 was granted by the Eurasian Patent Organization (EAPO), which includes nine member countries.

2005-10-29 09:51:59

Researchers are making a list: Which parts of an astronaut are most sensitive to solar flares?

Word of the Day
  • To swell, as grain or wood with water.
The word 'plim' is probably a variant of the word 'plum'.